Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03436446 · ClinicalTrials.gov registry record
Role of Social Incentives in PRO Collection
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 8
- Enrollment target
NCT03436446: Completed study, sponsored by Duke University.
NCT03436446 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03436446 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Value-based healthcare is heavily dependent on the accurate measurement of patient outcomes, both immediately after treatment and at long-term intervals. Patient reported outcomes (PROs) are often the central component of any quality improvement process as they are patient centered, reflect the ultimate objective of the intervention and are endorsed by many professional societies as the preferred physician performance metric. Although high response rates are critical to producing reliable data to support value-based payment models, quality improvement, and stakeholder transparency - especially in arthroscopy in which patients often fare well over time and may be less likely to continue with follow-up - response rates to outcome surveys after initial recovery from treatment are consistently below 50%. Monetary incentives offer only minor improvements in response rates against large increases in already rising costs. Individually tailored social incentives - as grounded in current behavioral economic practice - offer a potential cost-effective solution to this problem in Sports Medicine and arthroscopy. The investigators predict that well-constructed, personal social incentives will increase response rates for long-term follow-up of episodic care compared to control. The investigators predict these rates will vary depending on the patient demographics and other characteristics.
Primary Outcome
The investigators will use feedback from the interviews to adjust the social incentives.
Interventions
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-02-08 |
| Est. Completion | 2018-05-24 |
What the finished NCT03436446 record still lists
NCT03436446 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Interview is the first listed.
NCT03436446 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03436446 about?
NCT03436446 is a clinical study titled "Role of Social Incentives in PRO Collection". Value-based healthcare is heavily dependent on the accurate measurement of patient outcomes, both immediately after treatment and at long-term intervals. Patient reported outcomes (PROs) are often the central component of any quality improvement process as they are patient centered, reflect the ulti...
What is the current status of trial NCT03436446?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2018-02-08. Estimated completion is 2018-05-24.
What interventions are being tested in trial NCT03436446?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT03436446?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI